Roche Holding



Ebitda Endring Dato
AbbVie USD 6.92B 258M 2024-12
Alcon AG USD 514M 133M 2024-12
Almirall EUR 84.69M 66.19M 2024-06
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.08B 182M 2025-03
Bayer EUR 1.67B 3.36B 2024-12
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Fresenius EUR 972M 150M 2024-12
Fresenius Medical Care EUR 554.32M 256.68M 2024-12
Galapagos EUR -158708000 177.84M 2025-03
Genmab DKK 2.23B 85M 2024-09
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
GRIFOLS EUR 536.1M 85.37M 2024-12
Hikma Pharmaceutical USD 453M 98M 2024-06
Lonza CHF 873M 107M 2024-06
Merck EUR 1.42B 203M 2024-12
Merck USD 7.12B 1.06B 2024-12
Novartis USD 5.19B 319M 2024-12
Orion EUR 91.5M 55.5M 2025-03
Pfizer USD 6.21B 1.5B 2025-03
Philips EUR 945M 594M 2024-12
Recordati EUR 216.96M 25.45M 2024-09
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
UCB EUR 652M 105M 2024-06



Roche Holding - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.